Download PDF

Other users also viewed these articles

Hepatic manifestations and impact of COVID-19 on the cirrhotic patient J.A. Velarde-Ruiz Velasco; E.S. García-Jiménez; J.M. Remes-Troche;
Rev Gastroenterol Mex. 2020;85:303-11
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;
10.1016/j.rgmxen.2024.10.009
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms F. Higuera-de-la-Tijera; A. Servín-Caamaño; F. Lajud-Barquín; A. Tovar-Aguilar;
Rev Gastroenterol Mex. 2024;89:481-90